First Patient Dosed in Pivotal AFFINE Study of Potential Gene Therapy SB-525
News
The first participant was dosed with the investigational gene therapy treatment SB-525 (giroctocogene fitelparvovec) in a Phase 3 clinical trial in men with hemophilia A, according to developers Pfizer and ... Read more